Product Information
TRI-LO-SPRINTEC TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1083 per EA under NDC 00093214062. Its NADAC has been published 544 times since Mar 23, 2016.
FDA first approved this application on Jun 29, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093214062
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076784FDA Approved
6/29/2009
TE Code
AB
On Market Since
12/30/2015
Price Statistics
The NADAC for TRI-LO-SPRINTEC TABLET has been published 544 times since Mar 23, 2016, and over the history we have for it it has declined 90.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1083 per EA |
|---|---|
| All-time high | $1.1840 (Apr 13, 2016) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1148 |
| 52-week low | $0.1046 |
| Median price | $0.1724 |
| Average price | $0.2450 |
| Largest weekly change | -60.5% (Jan 18, 2017) |
| Weeks tracked | 544 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-LO-SPRINTEC TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-SPRINTEC TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1083 per EA (NDC 00093214062), effective Aug 19, 2026.
How has the price of TRI-LO-SPRINTEC TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-SPRINTEC TABLET has declined 90.9%. It has been tracked across 544 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for TRI-LO-SPRINTEC TABLET?
Since Mar 23, 2016, the NADAC for TRI-LO-SPRINTEC TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $1.1840 (Apr 13, 2016), with a median of $0.1724 per EA.
Are there cheaper alternatives to TRI-LO-SPRINTEC TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRI-LO-SPRINTEC TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRI-LO-SPRINTEC TABLET?
TRI-LO-SPRINTEC TABLET (NDC 00093214062) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.